Advent Technologies Holdings, Inc. Common Stock (ADN) EBITDA (2021 - 2025)
Advent Technologies Holdings, Inc. Common Stock (ADN) EBITDA from Mar 31, 2021 to Sep 30, 2025. The TTM Advent Technologies Holdings, Inc. Common Stock (ADN) EBITDA is -$16M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Advent Technologies Holdings, Inc. Common Stock (ADN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -51.58% |
| 3 Years TTM | -32.90% |
| All Time TTM | -28.27% |
Annual EBITDA change of Advent Technologies Holdings, Inc. Common Stock (ADN)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$7.64M | -54.47% |
| 2024 | -$17M | -56.32% |
| 2023 | -$38M | -16.62% |
| 2022 | -$46M | +6.67% |
| 2021 | -$43M | N/A |